Sumitomo Chemical Limited will host a group meeting for institutional investors and analysts on August 19, 2026, at 3:00 PM IST in Mumbai. The session aims to provide market participants with an opportunity to engage with company officials regarding business updates based solely on publicly available information. This engagement is part of the company’s ongoing efforts to maintain transparency and regular communication with its investor base under regulatory guidelines.

The event is organized by Motilal Oswal Financial Services Ltd. and is scheduled to commence at 3:00 PM onwards. Sumitomo Chemical India Limited confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the interaction, ensuring compliance with fair disclosure principles. The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company.

Meeting Details

This intimation was issued pursuant to Regulation 30(6) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) on August 10, 2026.

Deepika Trivedi, Company Secretary & Compliance Officer of Sumitomo Chemical India Limited, signed the communication. The company’s corporate office is located at 13/14, Aradhana IDC, Near Virwani Industrial Estate, Goregaon (East), Mumbai.

Regulatory Compliance

The disclosure aligns with SEBI’s mandate for listed entities to inform stock exchanges about scheduled interactions with investors and analysts. By restricting discussions to public information, Sumitomo Chemical ensures that all shareholders have equal access to material data, preventing selective dissemination of sensitive insights. The company retains the right to modify the schedule if operational exigencies arise.

Sumitomo Chemical has reaffirmed its financial guidance for the fiscal year ending in 2026, confirming both its revenue and earnings per share targets remain unchanged. The company stated that it expects total sales to reach $15.047 billion and GAAP earnings per share to stand at $1.35 for FY2026.

Guidance Details

The affirmation indicates that management sees no significant deviation from its earlier projections despite ongoing market conditions. The key metrics for the fiscal year are as follows:

What This Means

By maintaining these figures, Sumitomo Chemical signals confidence in its operational outlook and cost structure for the remainder of the fiscal year. Investors can expect the company’s performance to align with these previously disclosed benchmarks, providing stability in earnings expectations for FY2026.